Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 5.98 Delayed Data As of Jan 28 |  +0.37 / +6.60%Today’s Change | 2.53 Today|||52-Week Range 8.10 | +9.93% Year-to-Date |
Latest CRVS News | Press Releases
No recent news for Corvus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 5.61 |
| Today’s open | 5.64 |
| Day’s range | 5.63 - 6.09 |
| Volume | 177,494 |
| Average volume (3 months) | 170,886 |
| Market cap | $170.3M |
Data as of 4:00pm ET, 01/28/2020
Growth & Valuation
| Earnings growth (last year) | +37.27% |
| Earnings growth (this year) | +10.09% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.54 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| OBSVObseva SA | +0.09 | +2.40% |
| OVIDOvid Therapeutics In... | -0.05 | -1.46% |
| HROWHarrow Health Inc | +0.04 | +0.60% |
| ARCTArcturus Therapeutic... | -0.23 | -2.08% |
Data as of 4:00pm ET, 01/28/2020
Financials
| Next reporting date | March 9, 2020 |
| EPS forecast (this quarter) | -$0.33 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.9M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
